GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (FRA:31R) » Definitions » Purchase Of Business

Revive Therapeutics (FRA:31R) Purchase Of Business

: €0.00 Mil (TTM As of Dec. 2023)
View and export this data going back to 2017. Start your Free Trial

Revive Therapeutics's purchase of business for the three months ended in Dec. 2023 was €0.00 Mil. It means Revive Therapeutics spent €0.00 Mil on purchasing business. Revive Therapeutics's purchase of business for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Sep. 2023 ), Revive Therapeutics spent the same money on purchasing business in Dec. 2023 (€0.00 Mil).

Revive Therapeutics Purchase Of Business Historical Data

The historical data trend for Revive Therapeutics's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Purchase Of Business
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Revive Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Purchase Of Business Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Revive Therapeutics Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revive Therapeutics Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (FRA:31R) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (FRA:31R) » Definitions » Purchase Of Business
Comparable Companies
TSX:WLLW XCNQ:SLNG TSXV:NDVA XCNQ:IMCC TSX:CTX XCNQ:STHZ XCNQ:OILS XCNQ:XTRX TSX:VPH XCNQ:CANN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
RVVTF:USA RVV:Canada
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Website
https://www.revivethera.com
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

Revive Therapeutics (FRA:31R) Headlines

No Headlines